Antibacterial Designs for Implantable Medical Devices: Evolutions and Challenges

Area of Science:

• Biomaterials Science
• Infectious Diseases
• Medical Device Engineering

Background:

• Implantable medical devices are increasingly common, but device-associated infections (DAIs) persist as a leading complication.
• Despite a century of sterilization advancements, DAIs necessitate novel prevention and treatment strategies.
• Thousands of annual publications focus on antibacterial surfaces to combat DAIs.

Purpose of the Study:

• To categorize current research on antibacterial surfaces for DAIs.
• To highlight clinical features of DAIs to identify flaws in current antibacterial designs.
• To guide future directions for improved antibacterial designs and clinical translation.

Main Methods:

• Literature review and categorization of DAI research into four groups: long-term efficacy, cell-selective, responsiveness, and immune-instructive antibacterial surfaces.
• Analysis of clinical features of DAIs, including onset, incidence, and pathogen characteristics.
• Evaluation of current antibacterial designs against clinical requirements and intended use of devices.

Main Results:

• Current antibacterial surface research is often preliminary, lacking clear clinical scope.
• DAIs exhibit unpredictable onset, site-specific incidence, and can involve multiple resistant strains.
• A critical gap exists between preliminary research and the specific functional requirements of implantable devices.

Conclusions:

• Antibacterial surface designs must be tailored to the intended use of implantable medical devices.
• A deeper understanding of the device-pathogen-host relationship is crucial for effective DAI solutions.
• Future research should focus on bridging the gap between proof-of-concept studies and clinical applicability.